-The Indian Express   Maoists say target was Karma, demand pullout of forces Raipur: Claiming responsibility for Saturday's attack on the Congress convoy in Bastar which claimed 24 lives, the CPI (Maoist) said on Tuesday that the killing of senior party leaders was the "necessary revenge against the UPA's fascist Operation Green Hunt, which is being run in connivance with several state governments". "The primary aim behind this attack was to kill Mahendra Karma...

-The Hindu     The killings of Mahendra Karma and his colleagues call not for retributive violence but for a deeper reflection on the discontent among the tribals of central India and their dispossession In the summer of 2006, I had a long conversation with Mahendra Karma, the Chhattisgarh Congress leader who was killed in a terror attack by the Naxalites last week. I was not alone - with me were five other members...

-The Economic Times NEW DELHI: The government's ambitious manufacturing thrust has run into trouble even before it could take off with many states expressing difficulty in acquiring the vast tracts of land needed to set up dedicated zones. Five states have written to the Department of Industrial Policy and Promotion, requesting it to consider revising the minimum land requirement (from existing 5,000 hectare) for developing National Manufacturing Investment Zones (NMIZs). These include Assam,...

-The Hindu Raipur: Launching the Congress party's ‘Parivartan Yatra' (March for Change) on Thursday in Bastar, a senior Central Minister, Jairam Ramesh, compared Mahendra Karma, the tribal leader, with a "slow tiger." "Mahendra Karma was called the ‘Bastar Tiger.' But the tiger has slowed down over the years," said the Minister in the presence of Mr. Karma and about two thousand Gond tribals. Sitting on the dais, Mr. Karma's reactions changed...

-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...